Ctla4/cd28ig hybrid fusion proteins

Details Ctla4/cd28ig hybrid fusion proteins Ctla4/cd28ig hybrid fusion proteins

C - Chemistry, Metallurgy

12

N

C12N 15/62 (2006.01) A61K 38/17 (2006.01) A61K 39/395 (2006.01) C07K 14/705 (2006.01) C07K 14/725 (2006.01) C07K 16/24 (2006.01) C07K 16/28 (2006.01) C07K 16/42 (2006.01) C07K 19/00 (2006.01) C12N 5/10 (2006.01) C12N 15/12 (2006.01) C12N 15/13 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2146895

CTLA4 MOLECULES AND IL4-BINDING MOLECULES AND USES THEREOF ABSTRACT OF THE INVENTION The invention identifies the CTLA4 receptor as a ligand for the B7 antigen. The complete amino acid sequence encoding human CTLA4 receptor gene is provided. Methods are provided for expressing CTLA4 as an immunoglobulin fusion protein, for preparing hybrid CTLA4 fusion proteins, and for using the soluble fusion proteins, fragments and derivatives thereof, including monoclonal antibodies reactive with B7 and CTLA4, to regulate T cell interactions and immune responses mediated by such interactions.

Affiliated with

Also associated with

Rating

Ctla4/cd28ig hybrid fusion proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ctla4/cd28ig hybrid fusion proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ctla4/cd28ig hybrid fusion proteins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1533453